100%
Back to table
#018HormoneInjectable

GHRP-2

Symbol G2 · MW 817 Da

Educational onlyNot medical adviceSource links included

Synthetic ghrelin mimetic that stimulates GH secretion.

Discovered
1993
Half-life
30 minutes
Approval
Not FDA-approved

Quick facts

Category
Hormone
Route
Injectable
Molecular weight
817 Da
Half-life
30 minutes
Discovered
1993
Approval status
Not FDA-approved

Reported effects

  • GH release
  • Appetite increase
  • Lean mass

Overview

GHRP-2 is a growth hormone-releasing peptide that stimulates the pituitary gland to release growth hormone through ghrelin-related receptors. It is commonly associated with recovery, body composition, sleep support, and muscle maintenance. GHRP-2 may also influence appetite and other hormone pathways, which makes it different from more selective growth hormone peptides. Its purpose is to increase natural GH signaling rather than directly introduce growth hormone into the body. As a hormone peptide, GHRP-2 is often discussed for its role in growth hormone stimulation, recovery enhancement, and metabolic support.

Evidence context

GHRP-2 evidence summary

Human clinical evidence

GHRP-2 has an approval context listed in the Peptidic database. Approved use still depends on the specific indication, formulation, labeling, and clinician guidance.

Animal, preclinical, or formulation evidence

GHRP-2 may be discussed in animal, preclinical, in vitro, or early-stage research contexts. Those evidence types are useful for orientation but should not be treated as equivalent to approved human indications.

Status and evidence strength

Peptidic lists the approval status for GHRP-2 as Not FDA-approved. The reported effects below are reference fields from the peptide database, not medical promises. Source links are included later on the page when available so readers can continue review from primary or reputable sources.

How it's taken

Injectable
Typical Administration
Injectable
Typical Dosage
No established approved dosage; commonly referenced range is 100–300 mcg per injection
Typical Frequency
1–3 times daily

Dosing depends on the approved indication, formulation, titration schedule, and clinician guidance. This page is educational and not a substitute for medical advice.

Research sources

Source links included from peer-reviewed literature, clinical records, and medical databases for educational research context on GHRP-2.

Internal links

Related peptides

Hormone peptides

Frequently asked questions

What category is GHRP-2 in?

GHRP-2 is listed in the Hormone category on Peptidic.

What route is GHRP-2 associated with?

GHRP-2 is associated with the injectable route in the Peptidic database. This is descriptive route context, not a use instruction.

Is GHRP-2 approved?

Peptidic lists the approval status for GHRP-2 as: Not FDA-approved. Approval details can vary by indication and jurisdiction.

Interested in GHRP-2?

Enter your email and we'll send our recommended peptide vendor for educational research reference.

Review the peptide vendor research checklist

Educational reference only · No spam · Unsubscribe anytime

For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions. Explore the full peptide database, peptide calculator, or peptide tracker.

Last reviewed for educational accuracy: 2026-06-01